Gallbladder and biliary tract - GentsRates per 100,000 inhabitants
Table 1: Incidence: frequencies, crude and standardized rates per year
Incidence | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 1999‑2006 |
---|
Count | 43 | 43 | 48 | 48 | 55 | 43 | 46 | 35 | 361 |
---|
Crude rate | 7.2 | 7.3 | 8.1 | 8.2 | 9.5 | 7.2 | 7.5 | 5.7 | 7.6 (6.8‑8.4) |
---|
Standardized rate | Italy 2001 | 7.2 | 7.8 | 8.2 | 8.1 | 9.3 | 7.0 | 7.5 | 5.8 | 7.6 (6.8‑8.5) |
---|
Standardized rate | Europe | 4.9 | 4.5 | 5.3 | 5.3 | 5.8 | 4.3 | 4.7 | 3.5 | 4.8 (4.3‑5.3) |
---|
Standardized rate | World | 3.3 | 2.8 | 3.6 | 3.5 | 3.8 | 2.9 | 3.0 | 2.1 | 3.1 (2.8‑3.5) |
---|
Table 2: Mortality: frequencies, crude and standardized rates per year
Mortality | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 1999‑2006 |
---|
Count | 34 | 34 | 29 | 29 | 27 | 25 | 27 | 17 | 222 |
---|
Crude rate | 5.7 | 5.7 | 4.9 | 5.0 | 4.6 | 4.2 | 4.4 | 2.7 | 4.7 (4.1‑5.3) |
---|
Standardized rate | Italy 2001 | 5.7 | 6.1 | 5.0 | 5.1 | 4.6 | 4.3 | 4.3 | 3.0 | 4.7 (4.1‑5.4) |
---|
Standardized rate | Europe | 3.8 | 3.6 | 3.0 | 2.8 | 2.8 | 2.5 | 2.5 | 1.7 | 2.9 (2.5‑3.3) |
---|
Standardized rate | World | 2.5 | 2.3 | 2.0 | 1.7 | 1.8 | 1.5 | 1.6 | 1.0 | 1.8 (1.6‑2.1) |
---|
Table 3: Register quality indicators per year
Indicator | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 1999‑2006 |
---|
Mortality/Incidence ratio (%) | 79.2 | 78.2 | 61.0 | 63.0 | 49.5 | 61.4 | 57.3 | 51.7 | 61.8 |
---|
Cito-histologically confirmed (%) | 65.1 | 65.1 | 66.7 | 72.9 | 56.4 | 65.1 | 65.2 | 57.2 | 64.3 |
---|
Death certificate only - DCO (%) | 7.0 | 0.0 | 2.1 | 4.2 | 0.0 | 0.0 | 0.0 | 2.9 | 1.9 |
---|
Table 4: Comparison of Italian Registries mean prevalence by macro-areas
_ | Milan | North West | North East | Centre | South | Italy |
---|
Incidence | 4.6 | 5.3 | 4.3 | 4.6 | 5.2 | 4.6 |
---|
Mortality | 2.4 | 3.7 | 3.4 | 3.1 | 3.2 | 3.4 |
---|
Table 5: Basis of diagnosis per period
_ | 1999‑2002 | % | 2003‑2006 | % | 1999‑2006 | % |
---|
Histological | 118 | 64.8 | 96 | 53.6 | 214 | 59.3 |
---|
Citological | 5 | 2.8 | 13 | 7.3 | 18 | 5.0 |
---|
Clinical | 53 | 29.1 | 69 | 38.6 | 122 | 33.8 |
---|
DCO | 6 | 3.3 | 1 | 0.6 | 7 | 1.9 |
---|
Table 6: More frequent morphologies
Morphology | N | % |
---|
Adenocarcinoma, NOS | 86 | 78.9 |
---|
Tumour cells, malignant | 7 | 6.4 |
---|
Mucinous adenocarcinoma | 3 | 2.8 |
---|
Adenosquamous carcinoma | 2 | 1.8 |
---|
Carcinoma, NOS | 2 | 1.8 |
---|
Neoplasm, malignant | 1 | 0.9 |
---|
Table 7: Age distribution of rates
Age groups | Incidence | Mortality |
---|
0 | 0.0 | 0.0 |
---|
1-4 | 0.0 | 0.0 |
---|
5-9 | 0.0 | 0.0 |
---|
10-14 | 0.0 | 0.0 |
---|
15-19 | 0.0 | 0.0 |
---|
20-24 | 0.0 | 0.0 |
---|
25-29 | 0.0 | 0.0 |
---|
30-34 | 0.4 | 0.0 |
---|
35-39 | 0.4 | 0.0 |
---|
40-44 | 1.0 | 0.0 |
---|
45-49 | 0.6 | 0.6 |
---|
50-54 | 5.4 | 1.4 |
---|
55-59 | 3.8 | 1.3 |
---|
60-64 | 10.2 | 5.7 |
---|
65-69 | 16.5 | 9.3 |
---|
70-74 | 29.1 | 12.6 |
---|
75-79 | 40.6 | 21.4 |
---|
80-84 | 47.8 | 34.2 |
---|
85+ | 46.9 | 35.2 |
---|
Table 8: Temporal trends of rates
Year | Mortality | Incidence |
---|
1999 | 3.8 | 4.9 |
---|
2000 | 3.6 | 4.5 |
---|
2001 | 3.0 | 5.3 |
---|
2002 | 2.8 | 5.3 |
---|
2003 | 2.8 | 5.8 |
---|
2004 | 2.5 | 4.3 |
---|
2005 | 2.5 | 4.7 |
---|
2006 | 1.7 | 3.5 |
---|
Table 10: Comparison of Italian Registries mean prevalence by macro-areas
Years since diagnosis | Italy | South | Centre | North East | North West | Milan |
---|
0-2 | 5.9 | 5.2 | 6.3 | 5.5 | 6.8 | 6.3 |
---|
2-5 | 2.9 | 2.2 | 2.4 | 2.6 | 4.2 | 4.4 |
---|
5-10 | 2.4 | 2.2 | 3.1 | 2.4 | 2.1 | 1.8 |
---|
10-15 | 1.0 | 0.8 | 1.2 | 0.6 | 1.8 | 1.1 |
---|
15-20 | 0.6 | 0.5 | 0.6 | 0.4 | 0.8 | 0.5 |
---|
>20 | 0.4 | 0.2 | 0.4 | 0.4 | 0.5 | 0.3 |
---|
Table 11: 5 years relative survival by macro-areas
Area | Relative survival (95% CI) |
---|
Milan | 22.1 (15.9‑28.4) |
---|
North West | 16.8 (13.8‑20.1) |
---|
North Est | 17.5 (14.6‑20.6) |
---|
Centre | 17.5 (13.0‑22.6) |
---|
South | 14.6 (11.0‑18.8) |
---|
Italy | 16.9 (15.1‑18.8) |
---|
Table 12: Relative survival by age since diagnosis
Age class | 0 | 1 | 2 | 3 | 4 | 5 |
---|
15-44 | 100.00 | 51.50 | 46.40 | 38.00 | 38.00 | 38.00 |
---|
45-59 | 100.00 | 41.10 | 26.40 | 21.20 | 17.00 | 16.10 |
---|
60-74 | 100.00 | 26.90 | 16.90 | 15.90 | 15.30 | 12.80 |
---|
Table 13: 5 years relative survival by biennium of incidence
Years since diagnosis | 1999‑2000 | 2001‑2002 | 2003‑2004 | 2005‑2006 |
---|
1 | 30.1 | 40 | 33.8 | 41.6 |
---|
2 | 13 | 28.8 | 25.7 | 30.1 |
---|
3 | 6.7 | 26 | 21.6 | 26.5 |
---|
4 | 5.4 | 21.9 | 20.9 | 22.9 |
---|
5 | 5.4 | 18.8 | 20.2 | 20.5 |
---|
Table 14: Rates distribution by deprivation index
‑ | 1 | 2 | 3 | 4 | 5 |
---|
Incidence | 7.3 | 7.3 | 4.9 | 8.1 | 7.5 |
---|
Mortality | 2.9 | 3.5 | 3.1 | 4.9 | 4.6 |
---|
Table 15: Relative survival by deprivation index
Years since diagnosis | Most deprived | Most affluent |
---|
0 | 100.0 | 100.0 |
---|
1 | 27.1 | 29.5 |
---|
2 | 9.5 | 20.3 |
---|
3 | 6.3 | 13.1 |
---|
4 | 6.3 | 10.7 |
---|
5 | 3.6 | 5.5 |
---|